The mazdutide versus tirzepatide comparison is complicated by the fact that most mazdutide data comes from East Asian populations, which may respond differently to weight loss medications
If invited, proposers will submit a Technical Oral Presentation (Pitch), Cost Proposal, and Task Description Document (deadline TBD)
Some patients reach their target weight at lower doses, while others need gradual increasesindividual response varies based on genetics, metabolism, and weight-loss history
This maximum dose produced the greatest weight reduction in SURMOUNT trials, with average weight loss of approximately 22% of baseline body weight over 72 weeks of continuous therapy
Two such promising medications, Ozempic (semaglutide) and retatrutide, have gained considerable attention for their potential to facilitate substantial weight loss